CARWIN PHARMACEUTICAL ASSOCIATES

Serial Number 97744366
Registration 7351111
700

Registration Progress

Application Filed
Jan 6, 2023
Under Examination
Approved for Publication
Jan 23, 2024
Published for Opposition
Jan 23, 2024
Registered
Apr 9, 2024

Trademark Image

CARWIN PHARMACEUTICAL ASSOCIATES

Basic Information

Serial Number
97744366
Registration Number
7351111
Filing Date
January 6, 2023
Registration Date
April 9, 2024
Published for Opposition
January 23, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Apr 9, 2024
Registration
Registered
Classes
005

Rights Holder

Carwin Pharmaceutical Associates, LLC

16
Address
1301 Highway 36, Suite 11
Hazlet, NJ 07730

Ownership History

Carwin Pharmaceutical Associates, LLC

Original Applicant
16
Hazlet, NJ

Carwin Pharmaceutical Associates, LLC

Owner at Publication
16
Hazlet, NJ

Carwin Pharmaceutical Associates, LLC

Original Registrant
16
Hazlet, NJ

Legal Representation

Attorney
Zoe Bernstein

USPTO Deadlines

Next Deadline
1715 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-04-09)
Due Date
April 09, 2030
Grace Period Ends
October 09, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

15 events
Date Code Type Description Documents
Apr 9, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Apr 9, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jan 23, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 23, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 3, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 20, 2023 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 19, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 18, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 18, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Sep 30, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Sep 30, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
Sep 30, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Sep 29, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 30, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 10, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Vitamins; Allergy medication; Nutritional supplements; Pharmaceutical preparations for the treatment of pain associated with inflammation, chronic inflammatory disease of musculoskeletal system, post-traumatic inflammation of soft tissue and musculoskeletal system, pain in the spine, neuralgia, myalgia, arthralgia, pain and inflammation after surgery or injury, pain in gout, and migraine; Vitamin and mineral supplements; Prenatal vitamins
First Use Anywhere: Jun 1, 2014
First Use in Commerce: Jun 1, 2014

Additional Information

Other
the mark CARWIN PHARMACEUTICAL ASSOCIATES has become distinctive of the goods/services through the applicant's substantially exclusive and continuous use of the mark in commerce that the U.S. Congress may lawfully regulate for at least the five years immediately before the date of this statement.

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PHARMACEUTICAL ASSOCIATES"